David Ramsay, M.B.A.

Mr. Ramsay has been a Director of EXUMA Biotech since January 2017.  In 2018, Mr. Ramsay served as Senior Vice President and Chief Financial Officer of Bonti, Inc.  Mr. Ramsay retired from Halozyme Therapeutics, Inc. (NASDAQ: HALO) in July 2015, where he served as Chief Financial Officer since May 2013 and from 2003-2009.  He also served as Halozyme’s Vice President, Corporate Development from 2009-2013.  From 2000-2003, Mr. Ramsay was Vice President and Chief Financial Officer of Lathian Systems, Inc., a provider of technology-based sales solutions for the life science industry.  From 1998-2000, he was with Valeant Pharmaceuticals International, Inc. (formerly ICN Pharmaceuticals, Inc.), where he served as Vice President, Treasurer and Director, Corporate Finance.  Mr. Ramsay began his career at Deloitte & Touche, where he obtained his C.P.A. license.  Mr. Ramsay also serves on the boards of Savara Pharmaceuticals (NASDAQ: SVRA) and La Jolla Pharmaceutical (NASDAQ: LJPC).

Mr. Ramsay holds a B.S. in business administration from the University of California, Berkeley and a M.B.A. with a dual major in finance and strategic management from The Wharton School at the University of Pennsylvania.